Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.44 HKD | -9.33% | -14.33% | -55.26% |
Jun. 03 | Oncosil Medical Treats 200th Pancreatic Cancer Patient with Proprietary Device | MT |
May. 02 | OncoSil Medical Raises AU$5.3 Million under Entitlement Offer | MT |
Sales 2024 * | 321M 44.35M 346M | Sales 2025 * | 426M 58.75M 459M | Capitalization | 3.16B 436M 3.41B |
---|---|---|---|---|---|
Net income 2024 * | -117M -16.14M -126M | Net income 2025 * | -34M -4.69M -36.65M | EV / Sales 2024 * | 6.97 x |
Net cash position 2024 * | 922M 127M 994M | Net cash position 2025 * | 931M 128M 1B | EV / Sales 2025 * | 5.24 x |
P/E ratio 2024 * |
-26.8
x | P/E ratio 2025 * |
-91.8
x | Employees | 124 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.91% |
1 day | -9.33% | ||
1 week | -14.33% | ||
Current month | -24.23% | ||
1 month | -32.34% | ||
3 months | -45.55% | ||
6 months | -46.67% | ||
Current year | -55.26% |
Managers | Title | Age | Since |
---|---|---|---|
Zhiyong Pan
CEO | Chief Executive Officer | 47 | Jan. 11 |
Davin Wu
DFI | Director of Finance/CFO | 39 | 22-03-08 |
Jon Randle
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chun Shun Ko
BRD | Director/Board Member | 72 | - |
Shing Yim Chau
BRD | Director/Board Member | 60 | 18-04-15 |
Ka Chun Tiu
BRD | Director/Board Member | 47 | 19-07-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 5.44 | -9.33% | 6 733 000 |
24-06-04 | 6 | -9.77% | 6,015,500 |
24-06-03 | 6.65 | -7.38% | 3,148,392 |
24-05-31 | 7.18 | +4.97% | 11,132,890 |
24-05-30 | 6.84 | +5.07% | 1,758,000 |
Delayed Quote Hong Kong S.E., June 05, 2024 at 04:08 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-55.26% | 481M | |
+43.70% | 59.97B | |
+84.80% | 10.96B | |
+25.59% | 1.3B | |
+63.70% | 513M | |
+150.77% | 414M | |
-53.47% | 328M | |
0.00% | 116M | |
-66.37% | 102M | |
-33.90% | 95.4M |
- Stock Market
- Equities
- 863 Stock